UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000039968 |
|---|---|
| Receipt number | R000045562 |
| Scientific Title | An exploratory biomarker study in an investigator initiated phase II trial of atezolizumab in patients with relapsed/refractory NK/T-cell lymphoma |
| Date of disclosure of the study information | 2020/03/28 |
| Last modified on | 2024/03/30 11:47:15 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2020/03/27 20:45:34 | ||
| 2 | Update | 2022/03/31 21:30:30 | Last follow-up date |
|
| 3 | Update | 2024/03/30 11:41:53 | Recruitment status |
|
| 4 | Update | 2024/03/30 11:47:15 | Number of participants that the trial has enrolled |
